Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.

PMID: 26024899
Journal: NEUROLOGY
Year: 2015
Reference: Neurology. 2015 Jul 7;85(1):29-39. doi: 10.1212/WNL.0000000000001706. Epub 2015 May 29.
Impact factor: 8.286
Publication type: Clinical Trials
Authors: Griffiths, Sarah, von Rosenstiel, Philipp, Gottschalk, Rebecca, Zhang, Ying, Dahlke, Frank, Tomic, Davorka, Mueller-Lenke, Nicole, Sprenger, Till, Derfuss, Tobias, Kappos, Ludwig et al.
DOI: 10.1212/WNL.0000000000001706

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.

PMID: 26024899
Journal: NEUROLOGY
Year: 2015
Reference: Neurology. 2015 Jul 7;85(1):29-39. doi: 10.1212/WNL.0000000000001706. Epub 2015 May 29.
Impact factor:
Publication type: Clinical Trials
Authors: Butzkueven, Helmut; Comi, Giancarlo; Dahlke, Frank; Derfuss, Tobias; Giovannoni, Gavin; Gottschalk, Rebecca; Griffiths, Sarah; Hartung, Hans-Peter; Kappos, Ludwig; Montalban, Xavier et al.
DOI: 10.1212/WNL.0000000000001706

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

PMID: 25496141
Journal: HIV MEDICINE
Year: 2015
Reference: HIV Med. 2015 Jul;16(6):370-4. doi: 10.1111/hiv.12210. Epub 2014 Dec 11.
Impact factor: 3.454
Publication type: Paper in international publication
Authors: Martinez, E, Ribera, E, Clotet, B, Estrada, V, Sanz, J, Berenguer, J, Rubio, R, Pulido, F, Larrousse, M, Curran, A et al.
DOI: 10.1111/hiv.12210

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

PMID: 25496141
Journal: HIV MED
Year: 2015
Reference: HIV Med. 2015 Jul;16(6):370-4. doi: 10.1111/hiv.12210. Epub 2014 Dec 11.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez, Ml; Arterburn, S; Berenguer, J; Clotet, B; Curran, A; Estrada, V; Ferrer, P; Larrousse, M; Martinez, E; Negredo, E et al.
DOI: 10.1111/hiv.12210

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months.

PMID: 25756742
Journal: Cancer Medicine
Year: 2015
Reference: Cancer Med. 2015 Jul;4(7):995-1002. doi: 10.1002/cam4.440. Epub 2015 Mar 10.
Impact factor: 2.5
Publication type: Paper in international publication
Authors: Garcia-Gutierrez, Jose-Valentin, Massague, Isabel, Giraldo, Pilar, Perez-Encinas, Manuel, de Paz, Raquel, Martinez-Lopez, Joaquin, Bautista, Guiomar, Osorio, Santiago, Requena, Maria-Jose, Palomera, Luis et al.
DOI: 10.1002/cam4.440

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months.

PMID: 25756742
Journal: CANCER MED-US
Year: 2015
Reference: Cancer Med. 2015 Jul;4(7):995-1002. doi: 10.1002/cam4.440. Epub 2015 Mar 10.
Impact factor:
Publication type: Paper in international publication
Authors: Bautista, Guiomar; Burgaleta, Carmen; Calle, Carmen; Casado, Luis-Felipe; de Paz, Raquel; Garcia-Gutierrez, Jose-Valentin; Garcia-Ormena, Nuria; Giraldo, Pilar; Hernandez-Rivas, Jose-Angel; Maestro, Begona et al.
DOI: 10.1002/cam4.440

Syncope Unit: rationale and requirement - the European Heart Rhythm Association position statement endorsed by the Heart Rhythm Society.

PMID: 26108809
Journal: EUROPACE
Year: 2015
Reference: Europace. 2015 Sep;17(9):1325-40. doi: 10.1093/europace/euv115. Epub 2015 Jun 24.
Impact factor: 3.67
Publication type: Paper in international publication
Authors: Benditt, David, Krahn, Andrew, Morillo, Carlos Arturo, Olshansky, Brian, Raj, Satish, Sheldon, Robert, Shen, Win Kuang, Sun, Benjamin, Hachul, Denise, Abe, Haruhiko et al.
DOI: 10.1093/europace/euv115

Syncope Unit: rationale and requirement - the European Heart Rhythm Association position statement endorsed by the Heart Rhythm Society.

PMID: 26108809
Journal: EUROPACE
Year: 2015
Reference: Europace. 2015 Sep;17(9):1325-40. doi: 10.1093/europace/euv115. Epub 2015 Jun 24.
Impact factor:
Publication type: Paper in international publication
Authors: Abe, Haruhiko; Asgari, Mehran; Baron-Esquivias, Gonzalo; Benditt, David; Blanc, Jean-Jacques; Brignole, Michele; Casagranda, Ivo; Cohen, Mitchell; Cunnigham, Conal; Dan, Gheorghe-Andrei et al.
DOI: 10.1093/europace/euv115

Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.

PMID: 25761863
Journal: HEPATOLOGY
Year: 2015
Reference: Hepatology. 2015 Sep;62(3):762-72. doi: 10.1002/hep.27779. Epub 2015 Apr 13.
Impact factor: 11.055
Publication type: Paper in international publication
Authors: Affo, Silvia, Morales-Ibanez, Oriol, Sancho-Bru, Pau, Dominguez, Marlene, Garcia-Pagan, Juan Carlos, Fernandez, Javier, Arroyo, Vicente, Gines, Pere, Louvet, Alexandre, Mathurin, Philippe et al.
DOI: 10.1002/hep.27779

Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.

PMID: 25761863
Journal: HEPATOLOGY
Year: 2015
Reference: Hepatology. 2015 Sep;62(3):762-72. doi: 10.1002/hep.27779. Epub 2015 Apr 13.
Impact factor:
Publication type: Paper in international publication
Authors: Abraldes, Juan G; Affo, Silvia; Altamirano, Jose; Arroyo, Vicente; Bataller, Ramon; Caballeria, Juan; Dominguez, Marlene; Fernandez, Javier; Garcia-Pagan, Juan Carlos; Gines, Pere et al.
DOI: 10.1002/hep.27779

Takotsubo cardiomyopathy and elderly adults: still a benign condition?

PMID: 25688623
Journal: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Year: 2015
Reference: J Am Geriatr Soc. 2015 Feb;63(2):404-7. doi: 10.1111/jgs.13276.
Impact factor: 4.572
Publication type: Letter whit IF
Authors: Nunez-Gil, Ivan J, Sionis, Alessandro, Andres, Mireia, Almendro Delia, Manuel, Martin, Ana, Lozano, Alvaro, Cordoba Soriano, Juan Gabriel, Linares Vicente, Jose A, Gonzalez Sucarrats, Silvia, Sanchez Grande Flecha, Alejandro et al.
DOI: 10.1111/jgs.13276

Takotsubo cardiomyopathy and elderly adults: still a benign condition?

PMID: 25688623
Journal: J AM GERIATR SOC
Year: 2015
Reference: J Am Geriatr Soc. 2015 Feb;63(2):404-7. doi: 10.1111/jgs.13276.
Impact factor:
Publication type: Letter whit IF
Authors: Acena, Alvaro; Acuna, Jose Maria Garcia; Almendro Delia, Manuel; Andres, Mireia; Andres, Oscar Fabregat; Arcinegas, Andrea Moreno; Arroyo, Jose Ramon Ruiz; Barrabes, Jose A; Bascompte, Ramon; Bastante, Teresa et al.
DOI: 10.1111/jgs.13276

Tamoxifen administration to mice.

PMID: 25734062
Journal: Cold Spring Harbor protocols
Year: 2015
Reference: Cold Spring Harb Protoc. 2015 Mar 2;2015(3):269-71. doi: 10.1101/pdb.prot077966.
Impact factor: 0
Publication type: Paper in international publication
Authors: Whitfield, Jonathan, Littlewood, Trevor, Soucek, Laura et al.
DOI: 10.1101/pdb.prot077966

Tamoxifen administration to mice.

PMID: 25734062
Journal: Cold Spring Harbor protocols
Year: 2015
Reference: Cold Spring Harb Protoc. 2015 Mar 2;2015(3):269-71. doi: 10.1101/pdb.prot077966.
Impact factor:
Publication type: Paper in international publication
Authors: Littlewood, Trevor; Soucek, Laura; Whitfield, Jonathan et al.
DOI: 10.1101/pdb.prot077966

Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.

PMID: 25407002
Journal: EUROPEAN JOURNAL OF HUMAN GENETICS
Year: 2015
Reference: Eur J Hum Genet. 2015 Sep;23(9):1192-9. doi: 10.1038/ejhg.2014.252. Epub 2014 Nov 19.
Impact factor: 4.225
Publication type: Paper in international publication
Authors: Trujillano, Daniel, Santin, Sheila, Ossowski, Stephan, Mendizabal, Santiago, Fraga, Gloria, Madrid, Alvaro, Ariceta, Gema, Ballarin, Jose, Torra, Roser, Ars, Elisabet et al.
DOI: 10.1038/ejhg.2014.252

Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.

PMID: 25407002
Journal: EUR J HUM GENET
Year: 2015
Reference: Eur J Hum Genet. 2015 Sep;23(9):1192-9. doi: 10.1038/ejhg.2014.252. Epub 2014 Nov 19.
Impact factor:
Publication type: Paper in international publication
Authors: Ariceta, Gema; Ars, Elisabet; Ballarin, Jose; Bullich, Gemma; Fraga, Gloria; Madrid, Alvaro; Mendizabal, Santiago; Ossowski, Stephan; Santin, Sheila; Torra, Roser et al.
DOI: 10.1038/ejhg.2014.252

Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies.

PMID: 25725224
Journal: Discovery Medicine
Year: 2015
Reference: Discov Med. 2015 Feb;19(103):101-8.
Impact factor: 3.626
Publication type: Review in international publication
Authors: Agarwal, Rishi, Liebe, Sarah, Turski, Michelle L, Vidwans, Smruti J, Janku, Filip, Garrido-Laguna, Ignacio, Munoz, Javier, Schwab, Richard, Rodon, Jordi, Kurzrock, Razelle et al.
DOI:

Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies.

PMID: 25725224
Journal: DISCOV MED
Year: 2015
Reference: Discov Med. 2015 Feb;19(103):101-8.
Impact factor:
Publication type: Review in international publication
Authors: Agarwal, Rishi; Garrido-Laguna, Ignacio; Janku, Filip; Kurzrock, Razelle; Liebe, Sarah; Munoz, Javier; Rodon, Jordi; Schwab, Richard; Subbiah, Vivek; Turski, Michelle L et al.
DOI:

Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome.

PMID: 25725225
Journal: Discovery Medicine
Year: 2015
Reference: Discov Med. 2015 Feb;19(103):109-16.
Impact factor: 3.626
Publication type: Review in international publication
Authors: Agarwal, Rishi, Liebe, Sarah, Turski, Michelle L, Vidwans, Smruti J, Janku, Filip, Garrido-Laguna, Ignacio, Munoz, Javier, Schwab, Richard, Rodon, Jordi, Kurzrock, Razelle et al.
DOI:

Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome.

PMID: 25725225
Journal: DISCOV MED
Year: 2015
Reference: Discov Med. 2015 Feb;19(103):109-16.
Impact factor:
Publication type: Review in international publication
Authors: Agarwal, Rishi; Garrido-Laguna, Ignacio; Janku, Filip; Kurzrock, Razelle; Liebe, Sarah; Munoz, Javier; Rodon, Jordi; Schwab, Richard; Subbiah, Vivek; Turski, Michelle L et al.
DOI:

Targeting a cell state common to triple-negative breast cancers.

PMID: 25699542
Journal: Molecular Systems Biology
Year: 2015
Reference: Mol Syst Biol. 2015 Feb 19;11(1):789. doi: 10.15252/msb.20145664.
Impact factor: 10.872
Publication type: Paper in international publication
Authors: Kerzendorfer, Claudia, Lechtermann, Hannelore, Trefzer, Claudia, Klepsch, Freya, Muller, Andre C, Leitner, Ernestine, Macho-Maschler, Sabine, Superti-Furga, Giulio, Bennett, Keiryn L, Baselga, Jose et al.
DOI: 10.15252/msb.20145664

Targeting a cell state common to triple-negative breast cancers.

PMID: 25699542
Journal: MOL SYST BIOL
Year: 2015
Reference: Mol Syst Biol. 2015 Feb 19;11(1):789. doi: 10.15252/msb.20145664.
Impact factor:
Publication type: Paper in international publication
Authors: Baselga, Jose; Bennett, Keiryn L; Colinge, Jacques; Ibrahim, Yasir; Kerzendorfer, Claudia; Klepsch, Freya; Kubicek, Stefan; Lechtermann, Hannelore; Leitner, Ernestine; Macho-Maschler, Sabine et al.
DOI: 10.15252/msb.20145664

Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.

PMID: 26050140
Journal: LANCET NEUROLOGY
Year: 2015
Reference: Lancet Neurol. 2015 Aug;14(8):855-66. doi: 10.1016/S1474-4422(15)00006-X. Epub 2015 Jun 3.
Impact factor: 21.896
Publication type: Paper in international publication
Authors: Dehay, Benjamin, Bourdenx, Mathieu, Gorry, Philippe, Przedborski, Serge, Vila, Miquel, Hunot, Stephane, Singleton, Andrew, Olanow, C Warren, Merchant, Kalpana M, Bezard, Erwan et al.
DOI: 10.1016/S1474-4422(15)00006-X

Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.

PMID: 26050140
Journal: LANCET NEUROL
Year: 2015
Reference: Lancet Neurol. 2015 Aug;14(8):855-66. doi: 10.1016/S1474-4422(15)00006-X. Epub 2015 Jun 3.
Impact factor:
Publication type: Paper in international publication
Authors: Bezard, Erwan; Bourdenx, Mathieu; Dehay, Benjamin; Gorry, Philippe; Hunot, Stephane; Meissner, Wassilios G; Merchant, Kalpana M; Olanow, C Warren; Petsko, Gregory A; Przedborski, Serge et al.
DOI: 10.1016/S1474-4422(15)00006-X